aztreonam and beta-lactams

aztreonam has been researched along with beta-lactams in 66 studies

Research

Studies (66)

Timeframe	Studies, this research(%)	All Research%
pre-1990	19 (28.79)	18.7374
1990's	4 (6.06)	18.2507
2000's	12 (18.18)	29.6817
2010's	21 (31.82)	24.3611
2020's	10 (15.15)	2.80

Authors

Authors	Studies
Alemany, T; Martín-Villacorta, J; Méndez, R	1
Croize, J; Le Noc, D; Le Noc, P	1
Egger, HJ; Fischer, G	1
Mitani, M; Naeshiro, I; Tanayama, S; Torii, H; Yoshida, K	1
Imada, A; Kondo, M; Kuno, M; Okonogi, K; Yukishige, K	1
Hamana, Y; Inoue, M; Matsuda, K; Mitsuhashi, S	1
Egger, HJ; Stoeckel, K; Weidekamm, E; Ziegler, WH	1
Labthavikul, P; Neu, HC	1
Livermore, DM; Williams, JD	1
Andrews, JM; Hancox, J; Wise, R	1
Hart, CA; Karayiannis, P; Percival, A; Thomas, E	1
Bywater, MJ; Holt, HA; Reeves, DS	1
Russell, AD	1
Aklonis, CA; Gillum, AM; O'Sullivan, J; Souser, ML; Sykes, RB	1
Bonner, DP; Bush, K; Georgopapadakou, NH; Sykes, RB; Wells, JS	1
King, A; Phillips, I; Shannon, K; Warren, C	1
Bonner, DP; Bush, K; Georgopapadakou, N; Principe, PA; Sykes, RB; Trejo, WH; Wells, JS	1
Bonner, DP; Bush, K; Georgopapadakou, NH; Sykes, RB	1
Yokota, K	1
Hines, FA; Keim, GR; Miller, MM; Peterson, AE; Sibley, PL; Yoon, YH	1
Araki, H; Hayashi, T; Kitayama, R; Minami, S; Ochiai, H; Watanabe, Y	1
Coudron, PE; Moland, ES; Sanders, CC	1
Barry, AL; Brown, SD; Fuchs, PC	1
Giamarellou, H; Kavouklis, E; Kontoghiorgi, K; Voutsinas, D; Voutsinas, P	1
Stock, I; Wiedemann, B	1
Huynh, HK; Jones, RN; Sader, HS	1
Lee, WS; Lin, ML; Liu, CY; Wang, FD	1
Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J	1
Burgess, DS; Frei, CR	1
Jones, RN; Rhomberg, PR; Sader, HS	1
Alves Filho, JC; Cunha, FQ; D'Avila, LC; da Cunha, AA; de Oliveira, JR; Dias, FS; Leite, CE; Lunardelli, A; Machado, DP; Nunes, FB; Poli de Figueiredo, CE; Poloni, JA; Ruschel, RE; Saciura, VC; Simões Pires, MG	1
Iguchi, A; Kaneda, M; Kobayashi, R; Nakajima, M; Sato, T	1
Bou, G; Torres, E; Villanueva, R	1
Brémont, S; Conroy, MC; Courvalin, P; Lambert, T; Moubareck, C	1
Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS	1
Aruanno, A; Buonomo, A; Colagiovanni, A; De Pasquale, T; Lombardo, C; Nucera, E; Pascolini, L; Patriarca, G; Pecora, V; Rizzi, A; Sabato, V; Schiavino, D	1
Cabot, G; Juan, C; Mark, BL; Moyá, B; Oliver, A; Reeve, TM; Vocadlo, DJ; Zamorano, L	1
Abuzenadah, AM; Alam, Q; Azhar, EI; Damanhouri, GA; Jabir, NR; Kamal, MA; Shakil, S; Tabrez, S	1
El-Ghaiesh, S; Farrell, J; Hamlett, J; Jenkins, RE; Meng, X; Monshi, MM; Naisbitt, DJ; Park, BK; Peckham, D; Pirmohamed, M; Sanderson, JP; Whitaker, P; Yaseen, FS	1
Cao, X; Chen, H; Chen, J; Fang, Y; Lao, X; Shen, B; Shi, Y; Yu, Y; Zheng, H	1
Hekmaty, S; Kwon, DH; Seecoomar, G	1
Hiemenz, JW; Klinker, K; McCullough, BJ; Richards, A; Wiggins, LE; Wingard, JR	1
Chang, SC; Chen, PC; Huang, IW; Lai, JF; Lauderdale, TL; Shiau, YR; Tan, MC; Wang, HY; Wang, JT	1
Carlson, EE; Kocaoglu, O	1
Abdelhamed, AM; Bajaksouzian, S; Bonomo, RA; Foster, AN; Gatta, JA; Jacobs, MR; Nichols, WW; Papp-Wallace, KM; Testa, R; Winkler, ML	1
Bradford, PA; Eakin, AE; Harris, JJ; Kim, A; McLaughlin, RE; O'Donnell, JP; Patey, S; Singh, R; Tanudra, MA	1
Cattoir, V; Derdouri, S; Dupont, H; Emond, JP; Gaillard, N; Gaillot, O; Girard de Courtilles, M; Goetgheluck, AS; Lecuru, M; Lemaire, B; Mammeri, H; Plassart, C	1
Aldridge, PJ; Dupree, LH; Estep, PM; Ferreira, JA; Jankowski, CA	1
Banerjee, R; Boyce, TG; Cunningham, SA; Hasassri, ME; Jeraldo, PR; Kaye, KS; Norgan, AP; Patel, R; Pogue, JM; Weissman, SJ	1
Dixon, N; Fowler, RC; Geyer, CN; Hanson, ND; Harrison, L; Horiyama, T; Ishii, Y; Moland, ES; Thomson, K; Yoshizumi, A	1
Derendorf, H; Sy, SKB	1
Briand, ME; Clark, KE; Kapoor, O; Pirasteh, A	1
Ansari, M; Munir, T; Saad, N	1
Albanèse, J; Bornet, C; Curti, C; Fersing, C; Guinard, B; Lamy, E; Mathias, F; Primas, N; Souab, HK; Vanelle, P	1
Coleman, S; Eckburg, PB; Farinola, N; Keutzer, T; Kopp, E; Lister, T; Tomayko, J; Utley, L; Walpole, S	1
Cobian, J; Hall, B; Miller, J; Wilson, K	1
Chatzopoulou, F; Malousi, A; Meletis, G; Metallidis, S; Politi, L; Poulou, A; Protonotariou, E; Skoura, L; Tsakris, A	1
Maquieira, Á; Morais, S; Peña-Mendizabal, E	2
Anderson, WE; Hammer, J; Heffner, AC; Jaffa, RK; Medaris, LA; Pillinger, KE	1
Barnaby, R; Bashor, L; Gerber, SA; Hampton, TH; Hogan, DA; Kasetty, S; Koeppen, K; Kolling, FW; LaCroix, IS; Li, Z; Liefeld, AE; Nadell, CD; Nymon, A; Stanton, BA	1
Albur, M; Attwood, M; Bowker, KE; MacGowan, AP; Noel, AR	1
Axelrod, P; Holaday, E; Mishkin, A; Motzer, AR	1
Anstey, KM; Blumenthal, KG; Bystritsky, R; Doernberg, SB; Hilts-Horeczko, A; Le, VP; Lee, M; Li, F; Mulliken, JS; Otani, IM; Tang, M; Wang, L; Wattier, RL	1
Freret, C; Le Terrier, C; Nordmann, P; Poirel, L; Seigneur, M	1

Reviews

2 review(s) available for aztreonam and beta-lactams

Article	Year
[Progress of beta-lactam antibiotics. Special reference to monobactam (author's transl)]. The Japanese journal of antibiotics, 1981, Volume: 34, Issue:12 Topics: Acetobacter; Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Injections; Mice; Rats	1981
New Delhi metallo-β-lactamase (NDM-1): an update. Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam	2011

Article

Year

[Progress of beta-lactam antibiotics. Special reference to monobactam (author's transl)].

The Japanese journal of antibiotics, 1981, Volume: 34, Issue:12

Topics: Acetobacter; Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Injections; Mice; Rats

1981

New Delhi metallo-β-lactamase (NDM-1): an update.

Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:5

Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biotransformation; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Global Health; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Molecular Targeted Therapy; Sulbactam

2011

Trials

4 trial(s) available for aztreonam and beta-lactams

Article	Year
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:6 Topics: Adult; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Clinical Trials as Topic; Dialysis; Feces; Half-Life; Humans; Kidney Glomerulus; Kinetics; Male; Probenecid; Protein Binding; Ultrafiltration	1984
The effect of acetazolamide on the kinetics of four newer beta-lactams in the aqueous humor. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2001, Volume: 7, Issue:2 Topics: Acetazolamide; Aged; Aged, 80 and over; Aqueous Humor; Aztreonam; beta-Lactams; Cephalosporins; Drug Therapy, Combination; Endophthalmitis; Female; Humans; Male; Middle Aged	2001
Piperacillin/tazobactam plus ceftazidime versus sulbactam/ampicillin plus aztreonam as empirical therapy for fever in severely neutropenic pediatric patients. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:4 Topics: Adolescent; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Infant, Newborn; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Severity of Illness Index; Sulbactam	2009
Safety, Tolerability, Pharmacokinetics, and Drug Interaction Potential of SPR741, an Intravenous Potentiator, after Single and Multiple Ascending Doses and When Combined with β-Lactam Antibiotics in Healthy Subjects. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:9 Topics: Administration, Intravenous; Adult; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Area Under Curve; Aztreonam; beta-Lactams; Ceftazidime; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Female; Healthy Volunteers; Humans; Male; Piperacillin, Tazobactam Drug Combination	2019

Other Studies

60 other study(ies) available for aztreonam and beta-lactams

Article	Year
Stability in aqueous solution of two monocyclic beta-lactam antibiotics: aztreonam and nocardicin A. Chemical & pharmaceutical bulletin, 1992, Volume: 40, Issue:12 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Buffers; Catalysis; Drug Stability; Hydrogen-Ion Concentration; Kinetics; Lactams; Solutions; Structure-Activity Relationship; Temperature	1992
[Comparative antibacterial activity of a new monobactam, carumonam (RO 17-2301, AMA 1080) on hospital bacteria resistant to beta lactams]. Pathologie-biologie, 1987, Volume: 35, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cross Infection; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests	1987
Determination of the monocyclic beta-lactam antibiotic carumonam in plasma and urine by ion-pair and ion-suppression reversed-phase high-performance liquid chromatography. Journal of chromatography, 1987, Sep-25, Volume: 420, Issue:2 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Chromatography, High Pressure Liquid; Drug Stability; Drug Storage; Humans; Hydrogen-Ion Concentration; Temperature; Ultrafiltration	1987
Disposition of carumonam (AMA-1080/Ro 17-2301), a new N-sulfonated monocyclic beta-lactam, in rats and dogs. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:6 Topics: Animals; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Bile; Chromatography, Thin Layer; Dogs; Feces; Female; Male; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution	1986
In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:5 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; beta-Lactamases; beta-Lactams; Drug Stability; Female; Hydrolysis; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Protein Binding	1985
In-vitro antibacterial activity of AMA-1080. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Kinetics; Microbial Sensitivity Tests; Time Factors	1985
Antibacterial activity of a monocyclic beta-lactam SQ 26,776. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Pseudomonas aeruginosa	1981
In-vitro activity of the monobactam, SQ 26,776, against Gram-negative bacteria and its stability to their beta-lactamases. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Klebsiella pneumoniae; Plasmids; Pseudomonas aeruginosa	1981
SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Pseudomonas aeruginosa	1981
In-vitro activity of monobactam, SQ 26,776, against Gram-negative bacteria. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacteroides fragilis; beta-Lactamases; beta-Lactams; Chlamydia trachomatis; Drug Resistance, Microbial; Enterobacteriaceae; Klebsiella; Neisseria gonorrhoeae; Pseudomonas aeruginosa	1981
Antibacterial activity of the monobactam SQ 26,776 against antibiotic resistant enterobacteria, including Serratia spp. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Pseudomonas aeruginosa; Serratia	1981
In-vitro studies on SQ 26,776, a new monobactam antibiotic. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Escherichia coli; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus	1981
Biosynthesis of monobactam compounds: origin of the carbon atoms in the beta-lactam ring. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:4 Topics: Aztreonam; Bacteria; beta-Lactams; Cell-Free System; Chemical Phenomena; Chemistry; Culture Media; Cystine; Serine	1982
Monobactams--monocyclic beta-lactam antibiotics produced by bacteria. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria	1981
SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamases; beta-Lactams; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Aerobic Bacteria	1981
SQ 26,180, a novel monobactam. I Taxonomy, fermentation and biological properties. The Journal of antibiotics, 1982, Volume: 35, Issue:2 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carboxypeptidases; Carrier Proteins; Chromobacterium; Fermentation; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	1982
Azthreonam (SQ 26,776), a synthetic monobactam specifically active against aerobic gram-negative bacteria. Antimicrobial agents and chemotherapy, 1982, Volume: 21, Issue:1 Topics: Animals; Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Drug Stability; Female; Hexosyltransferases; Mice; Mice, Inbred Strains; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases	1982
Parenteral toxicological profile of the monocyclic beta-lactam antibiotic SQ 26,776 in mice, rats and dogs. The Journal of antimicrobial chemotherapy, 1981, Volume: 8 Suppl E Topics: Animals; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cecum; Dogs; Female; Heart; Injections, Intravenous; Injections, Subcutaneous; Kidney; Lethal Dose 50; Liver; Male; Mice; Rats; Time Factors	1981
In vitro antibacterial properties of T-5575 and T-5578 novel parenteral 2-carboxypenams. Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:12 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carrier Proteins; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Lactams; Microbial Sensitivity Tests; Monobactams; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding	1995
Occurrence and detection of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. Journal of clinical microbiology, 1997, Volume: 35, Issue:10 Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefpodoxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Enterobacteriaceae; Hospitals, Veterans; Isoelectric Focusing; Microbial Sensitivity Tests; Species Specificity; Substrate Specificity	1997
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates. Diagnostic microbiology and infectious disease, 1998, Volume: 32, Issue:4 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactams; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Monobactams	1998
beta-Lactam-susceptibility patterns of Plesiomonas shigelloides strains: importance of inoculum and medium. Scandinavian journal of infectious diseases, 2001, Volume: 33, Issue:9 Topics: Animals; Aztreonam; beta-Lactams; Carbapenems; Cephalosporins; Culture Media; Dogs; Humans; Microbial Sensitivity Tests; Penicillins; Plesiomonas	2001
Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli. Diagnostic microbiology and infectious disease, 2003, Volume: 47, Issue:3 Topics: Aztreonam; beta-Lactams; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sensitivity and Specificity	2003
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria. International journal of antimicrobial agents, 2004, Volume: 23, Issue:6 Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam	2004
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. International journal of antimicrobial agents, 2004, Volume: 24, Issue:6 Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests	2004
Continuous infusion beta-lactams for intensive care unit pulmonary infections. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Computer Simulation; Drug Combinations; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infusions, Intravenous; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; United States	2005
In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:6 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactams; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2005
Effects of beta-lactam antibiotics and L-arginine in the treatment of experimental sepsis in rats. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Animals; Arginine; Ascitic Fluid; Aztreonam; beta-Lactams; Ceftriaxone; Drug Therapy, Combination; Interleukin-10; Interleukin-1beta; Male; Nitrates; Nitrites; Rats; Rats, Wistar; Sepsis; Survival Analysis; Treatment Outcome; Tumor Necrosis Factor-alpha	2006
Comparison of different methods of determining beta-lactam susceptibility in clinical strains of Pseudomonas aeruginosa. Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 5 Topics: Anti-Bacterial Agents; Automation; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Genetic Predisposition to Disease; Humans; Imipenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections	2009
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Carbapenems; Integrons; Microbial Sensitivity Tests; Models, Genetic; Molecular Sequence Data; Plasmids	2009
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:8 Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary	2009
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA	2010
Tolerability of aztreonam in patients with cell-mediated allergy to β-lactams. International archives of allergy and immunology, 2011, Volume: 155, Issue:2 Topics: Adolescent; Adult; Aged; Angioedema; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cross Reactions; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Intradermal Tests; Male; Middle Aged; Patch Tests; Urticaria	2011
AmpG inactivation restores susceptibility of pan-beta-lactam-resistant Pseudomonas aeruginosa clinical strains. Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:5 Topics: Aztreonam; Bacterial Proteins; beta-Lactams; Cefepime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Membrane Transport Proteins; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Thienamycins	2011
β-Lactam antibiotics form distinct haptenic structures on albumin and activate drug-specific T-lymphocyte responses in multiallergic patients with cystic fibrosis. Chemical research in toxicology, 2013, Jun-17, Volume: 26, Issue:6 Topics: Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Cystic Fibrosis; Drug Hypersensitivity; Haptens; Humans; Hypersensitivity; Meropenem; Molecular Structure; Piperacillin; Serum Albumin; T-Lymphocytes; Thienamycins	2013
Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1). PloS one, 2013, Volume: 8, Issue:5 Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Hydrolysis; Kinetics; Meropenem; Molecular Docking Simulation; Recombinant Fusion Proteins; Thienamycins	2013
Homeostasis of glutathione is associated with polyamine-mediated β-lactam susceptibility in Acinetobacter baumannii ATCC 19606. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:11 Topics: Acinetobacter baumannii; Aztreonam; beta-Lactams; Biological Transport; Carbenicillin; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Glutathione; Homeostasis; Membrane Transport Proteins; Mutagenesis; Oxidation-Reduction; Spermidine; Spermine	2013
Aztreonam for febrile neutropenia in patients with beta-lactam allergy. Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Chemotherapy-Induced Febrile Neutropenia; Cohort Studies; Drug Hypersensitivity; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Treatment Outcome; Young Adult	2014
Antimicrobial susceptibilities of Proteus mirabilis: a longitudinal nationwide study from the Taiwan surveillance of antimicrobial resistance (TSAR) program. BMC infectious diseases, 2014, Sep-05, Volume: 14 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Longitudinal Studies; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Proteus Infections; Proteus mirabilis; Taiwan; Urinary Tract Infections; Young Adult	2014
Profiling of β-lactam selectivity for penicillin-binding proteins in Escherichia coli strain DC2. Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:5 Topics: Amdinocillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefotaxime; Cefuroxime; Escherichia coli; Microbial Sensitivity Tests; Penicillin-Binding Proteins	2015
Activities of ceftazidime, ceftaroline, and aztreonam alone and combined with avibactam against isogenic Escherichia coli strains expressing selected single β-lactamases. Diagnostic microbiology and infectious disease, 2015, Volume: 82, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Ceftaroline; Ceftazidime; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests	2015
Pharmacokinetics/pharmacodynamics of a β-lactam and β-lactamase inhibitor combination: a novel approach for aztreonam/avibactam. The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:9 Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactams; Disease Models, Animal; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Mice; Microbial Sensitivity Tests; Models, Biological; Treatment Outcome	2015
Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Ceftazidime; Dipeptides; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Ertapenem; France; Gene Expression; Humans; Microbial Sensitivity Tests; Plasmids; Prevalence; Prospective Studies	2016
Impact of an antimicrobial stewardship initiative to evaluate β-lactam allergy in patients ordered aztreonam. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2016, Mar-01, Volume: 73, Issue:5 Suppl 1 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; beta-Lactams; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Random Allocation; Retrospective Studies	2016
An Immunocompromised Child with Bloodstream Infection Caused by Two Escherichia coli Strains, One Harboring NDM-5 and the Other Harboring OXA-48-Like Carbapenemase. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Ciprofloxacin; Ertapenem; Escherichia coli; Female; Gentamicins; Humans; Immunocompromised Host; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam; Thienamycins; Tobramycin	2016
IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:10 Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Drug Resistance, Bacterial; Ertapenem; Hydrolysis; Integrons; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; United States	2016
Experimental design and modelling approach to evaluate efficacy of β-lactam/β-lactamase inhibitor combinations. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:7 Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Research Design	2018
Impact of a Standardized Beta-Lactam Allergy Questionnaire on Aztreonam Use. Journal of pharmacy practice, 2019, Volume: 32, Issue:4 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Documentation; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Pharmacists; Self Report; Students, Pharmacy; Surveys and Questionnaires	2019
Phenotypic Identification, Frequency Distribution and Antibiogram of Carbapenemase Producing Enterobacteriaceae in Clinical Isolates. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2018, Volume: 28, Issue:4 Topics: Amoxicillin; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; beta-Lactams; Carbapenem-Resistant Enterobacteriaceae; Clavulanic Acid; Disk Diffusion Antimicrobial Tests; Enterobacteriaceae Infections; Humans; Sensitivity and Specificity	2018
Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion. Die Pharmazie, 2019, 06-01, Volume: 74, Issue:6 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Imipenem; Meropenem; Piperacillin; Piperacillin, Tazobactam Drug Combination; Tazobactam	2019
Impact of SEP-1 on broad-spectrum combination antibiotic therapy in the emergency department. The American journal of emergency medicine, 2020, Volume: 38, Issue:12 Topics: Adult; Aged; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Centers for Medicare and Medicaid Services, U.S.; Early Diagnosis; Early Medical Intervention; Emergency Service, Hospital; Female; Guideline Adherence; Hospital Mortality; Hospitalization; Humans; Male; Medical Overuse; Meropenem; Middle Aged; Patient Care Bundles; Piperacillin, Tazobactam Drug Combination; Reimbursement Mechanisms; Retrospective Studies; Sepsis; Shock, Septic; Soft Tissue Infections; Time-to-Treatment; United States; Urinary Tract Infections; Vancomycin	2020
Clonal outbreak caused by VIM-4-producing Proteus mirabilis in a Greek tertiary-care hospital. International journal of antimicrobial agents, 2020, Volume: 56, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotyping Techniques; Greece; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Proteus Infections; Proteus mirabilis; Tertiary Care Centers; Whole Genome Sequencing; Young Adult	2020
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam. Scientific reports, 2020, 09-29, Volume: 10, Issue:1 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests	2020
Boosting the sensitivity of in vitroβ-lactam allergy diagnostic tests. Chemical communications (Cambridge, England), 2020, Oct-14, Volume: 56, Issue:80 Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbonates; Cohort Studies; Diagnostic Tests, Routine; Diamines; Drug Hypersensitivity; Female; Haptens; Humans; Lactams; Male; Middle Aged; Penicillin G; Serum Albumin, Human; Structure-Activity Relationship; Substrate Specificity	2020
Empiric aztreonam is associated with increased mortality compared to beta-lactams in septic shock. The American journal of emergency medicine, 2021, Volume: 48 Topics: Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; APACHE; Aztreonam; beta-Lactams; Cefepime; Cohort Studies; Drug Hypersensitivity; Female; Fluoroquinolones; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Shock, Septic	2021
Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of Proceedings of the National Academy of Sciences of the United States of America, 2021, 07-13, Volume: 118, Issue:28 Topics: Antagomirs; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Biofilms; Extracellular Vesicles; Gene Expression Regulation, Bacterial; Humans; MicroRNAs; Plankton; Pseudomonas aeruginosa	2021
Comparative bactericidal activity of representative β-lactams against Enterobacterales, Acinetobacter baumannii and Pseudomonas aeruginosa. The Journal of antimicrobial chemotherapy, 2022, 04-27, Volume: 77, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Piperacillin; Pseudomonas aeruginosa; Tazobactam	2022
Effects of reported beta-lactam allergies on pneumonia outcomes in lung transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:5 Topics: Acute Kidney Injury; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Clostridium Infections; Drug Hypersensitivity; Fluoroquinolones; Humans; Hypersensitivity; Lung; Pneumonia; Retrospective Studies; Transplant Recipients	2022
Impact of an Inpatient Allergy Guideline on β-Lactam and Alternative Antibiotic Use. The journal of allergy and clinical immunology. In practice, 2023, Volume: 11, Issue:8 Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cephalosporins; Drug Hypersensitivity; Humans; Hypersensitivity; Inpatients; Penicillins; Retrospective Studies	2023
Impact of Acquired Broad Spectrum β-Lactamases on Susceptibility to Novel Combinations Made of β-Lactams (Aztreonam, Cefepime, Meropenem, and Imipenem) and Novel β-Lactamase Inhibitors in Escherichia coli and Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 2023, 07-18, Volume: 67, Issue:7 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cefepime; Escherichia coli; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023